MINI FUTURE LONG - BB BIOTECH N Share Price

Certificat

BBBABP

CH0317912191

Market Closed - Swiss Exchange 16:20:00 23/05/2024 BST
2.14 CHF +0.94% Intraday chart for MINI FUTURE LONG - BB BIOTECH N
Current month-1.38%
1 month-0.93%
Date Price Change
23/05/24 2.14 +0.94%
21/05/24 2.12 -3.64%
17/05/24 2.2 +0.46%
15/05/24 2.19 +0.46%

Delayed Quote Swiss Exchange

Last update May 23, 2024 at 04:20 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying BB BIOTECH AG
IssuerLogo Issuer BNP Paribas BNP Paribas
BBBABP
ISINCH0317912191
Date issued 24/03/2016
Strike 19.92 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 1.12 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 6.27 CHF
Lowest since issue 0.69 CHF
Spread 0.02 CHF
Spread %0.93%

Company Profile

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
Sector
-
More about the company

Ratings for BB Biotech AG

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: BB Biotech AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
41.05 CHF
Average target price
47.7 CHF
Spread / Average Target
+16.20%
Consensus
  1. Stock Market
  2. Certificates
  3. BBBABP Certificat